1-20 of 90
lymphoma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.
https://doi.org/10.1182/hematology.2019000032
Published: 2019
Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.
https://doi.org/10.1182/hematology.2019001321
Published: 2019
Journal Articles

Common variable immune deficiency: case studies

Charlotte Cunningham-Rundles
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 449–456.
https://doi.org/10.1182/hematology.2019002062
Published: 2019
Journal Articles

Prognostication with circulating tumor DNA: is it ready for prime time?

David M. Kurtz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 47–52.
https://doi.org/10.1182/hematology.2019000013
Published: 2019
Journal Articles

Genomics of aggressive B-cell lymphoma

Allison Rosenthal, Lisa Rimsza
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 69–74.
https://doi.org/10.1182/asheducation-2018.1.69
Published: 2018
Journal Articles

Novel therapies for relapsed/refractory aggressive lymphomas

Jonathon B. Cohen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 75–82.
https://doi.org/10.1182/asheducation-2018.1.75
Published: 2018
Journal Articles

Novel immunotherapy approaches to follicular lymphoma

Christopher R. Flowers, John P. Leonard, Loretta J. Nastoupil
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 194–199.
https://doi.org/10.1182/asheducation-2018.1.194
Published: 2018
Journal Articles

Challenges and implications of genomics for T-cell lymphomas

Eric D. Jacobsen, David M. Weinstock
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 63–68.
https://doi.org/10.1182/asheducation-2018.1.63
Published: 2018
Journal Articles

Role of the microenvironment across histological subtypes of NHL

Karin Tarte
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 610–617.
https://doi.org/10.1182/asheducation-2017.1.610
Published: 2017
Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.
https://doi.org/10.1182/asheducation-2017.1.618
Published: 2017
Journal Articles

Developing T-cell therapies for lymphoma without receptor engineering

Melanie Grant, Catherine M. Bollard
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 622–631.
https://doi.org/10.1182/asheducation-2017.1.622
Published: 2017
Journal Articles

Current treatment of double hit and double expressor lymphoma

Patrick M. Reagan, Andrew Davies
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 295–297.
https://doi.org/10.1182/asheducation-2017.1.295
Published: 2017
Journal Articles

Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies

Kieron Dunleavy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 298–303.
https://doi.org/10.1182/asheducation-2017.1.298
Published: 2017
Journal Articles

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Andrés José María Ferreri
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 565–577.
https://doi.org/10.1182/asheducation-2017.1.565
Published: 2017
Journal Articles

Toward personalized treatment in Waldenström macroglobulinemia

Jorge J. Castillo, Steven P. Treon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 365–370.
https://doi.org/10.1182/asheducation-2017.1.365
Published: 2017
Journal Articles

Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy?

Nathan Fowler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 277–283.
https://doi.org/10.1182/asheducation-2016.1.277
Published: 2016
Journal Articles

Checkpoint inhibition and cellular immunotherapy in lymphoma

Premal Lulla, Helen E. Heslop
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 390–396.
https://doi.org/10.1182/asheducation-2016.1.390
Published: 2016
Journal Articles

Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?

Peter W. M. Johnson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 316–322.
https://doi.org/10.1182/asheducation-2016.1.316
Published: 2016
Journal Articles

Diffuse large B-cell lymphoma: R-CHOP failure—what to do?

Bertrand Coiffier, Clémentine Sarkozy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 366–378.
https://doi.org/10.1182/asheducation-2016.1.366
Published: 2016
Journal Articles

Treatment of patients with transformed lymphoma

Silvia Montoto
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 625–630.
https://doi.org/10.1182/asheducation-2015.1.625
Published: 2015